Oticon Medical Announces FDA Premarket Approval for Neuro Cochlear Implant System to Treat Severe to Profound Sensorineural Hearing Loss
With the expansion of its cochlear implant solutions to the US market, Oticon Medical is well positioned to become the worlds leading hearing expert within implantable hearing solutions.
- With the expansion of its cochlear implant solutions to the US market, Oticon Medical is well positioned to become the worlds leading hearing expert within implantable hearing solutions.
- People with severe to profound hearing loss in 51 countries already benefit from the Neuro System.
- View the full release here: https://www.businesswire.com/news/home/20210624005685/en/
Oticon Medical announces that the US Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the Neuro Cochlear Implant System to treat severe to profound sensorineural hearing loss. - The Neuro System is the first new cochlear implant technology to earn FDA premarket approval in more than 20 years.